文献速递生殖医学

评估用于未来自体移植的睾丸组织:聚焦血液恶性肿瘤男孩冻存组织中的癌细胞污染与精原细胞存在情况

Evaluating testicular tissue for future autotransplantation: focus on cancer cell contamination and presence of spermatogonia in tissue cryobanked for boys diagnosed with a hematological malignancy.
PubMed 文献 · Hum Reprod · 2024-01-01

这项回顾性队列研究纳入54名在性腺毒性治疗前接受睾丸活检的青春期前及围青春期血液恶性肿瘤男孩,对其中28例(急性淋巴细胞白血病14例、淋巴瘤14例)的福尔马林固定石蜡包埋组织进行癌细胞污染和精原细胞评估。免疫组化显示10/28(39%)存在癌细胞污染,急性淋巴细胞白血病组污染率57%(8/14)高于淋巴瘤组14%(2/14)(P值<0.05)。与健康参考队列相比,所有年龄组平均精原细胞数似乎降低,但基于Z分数的独立队列方法未能确认精原细胞数减少。

要点

  • 28例血液恶性肿瘤男孩冻存睾丸组织中,39%(11/28)检出癌细胞污染。
  • 急性淋巴细胞白血病组污染率57%(8/14),高于淋巴瘤组14%(2/14)(P值<0.05)。
  • 与健康参考队列相比,各年龄组平均精原细胞数似乎降低,但Z分数法未确认。

核心结论

  • 血液恶性肿瘤男孩诊断时采集的未成熟睾丸组织可能携带癌细胞,自体移植存在癌细胞再种植风险。
  • 所有患者精原细胞数似乎低于健康参考队列,但基于Z分数的独立队列方法未确认该减少。

研究设计与样本

  • 回顾性队列研究,纳入2005年至2021年间诊断时、任何性腺毒性治疗前接受睾丸活检的54名青春期前及围青春期血液恶性肿瘤男孩。
  • 54例中28例(急性淋巴细胞白血病14例、淋巴瘤14例)有福尔马林固定石蜡包埋睾丸组织可用于恶性细胞污染评估。

主要发现

  • 28名男孩诊断及睾丸活检时平均年龄7.5岁(年龄范围:19个月至16岁)。
  • 苏木精-伊红染色未检出恶性细胞;免疫组化使用疾病特异性标志物在28例中10例检出癌细胞污染。
  • 急性淋巴细胞白血病组污染率57%(8/14),高于淋巴瘤组14%(2/14)(P值<0.05)。
  • 15例诊断时骨髓有特定基因重排的患者中,PCR显示3例污染,其中1例免疫组化结果为阴性。
  • 与模拟对照队列健康患者青春期前各年龄段每生精小管精原细胞数参考值相比,所有年龄组平均精原细胞数似乎降低(0-4岁:1.49±0.54,4-7岁:1.08±0.43,7-11岁:1.56±0.65,11-14岁:3.37,14-16岁:5.44±3.14),但基于Z分数的独立队列方法未确认精原细胞数减少。

局限性

  • 用于评估癌细胞污染的活检碎片结果可能不能代表整个冻存未成熟睾丸组织,活检范围外仍可能存在肿瘤灶。
  • 血液恶性肿瘤对精原细胞数的影响有待进一步探索。
  • 该策略需要开发适配的生育力恢复方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the contamination rate by cancer cells and spermatogonia numbers in immature testicular tissue (ITT) harvested before the start of gonadotoxic therapy in boys with a hematological malignancy? SUMMARY ANSWER: Among our cohort of boys diagnosed with acute lymphoblastic leukemia (ALL) and lymphomas, 39% (n = 11/28) had cancer cells identified in their tissues at the time of diagnosis and all patients appeared to have reduced spermatogonia numbers compared to healthy reference cohorts. WHAT IS KNOWN ALREADY: Young boys affected by a hematological cancer are at risk of contamination of their testes by cancer cells but histological examination is unable to detect the presence of only a few cancer cells, which would preclude autotransplantation of cryobanked ITT for fertility restoration, and more sensitive detection techniques are thus required. Reduced numbers of spermatogonia in ITT in hematological cancer patients have been suggested based on results in a limited number of patients. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included 54 pre- and peri-pubertal boys who were diagnosed with a hematological malignancy and who underwent a testicular biopsy for fertility preservation at the time of diagnosis before any gonadotoxic therapy between 2005 and 2021. PARTICIPANTS/MATERIALS, SETTING, METHODS: Among the 54 patients eligible in our database, formalin-fixed paraffin-embedded (FFPE) testicular tissue was available for 28 boys diagnosed either with ALL (n = 14) or lymphoma (n = 14) and was used to evaluate malignant cell contamination. Hematoxylin and eosin (H&E) staining was performed for each patient to search for cancer cells in the tissue. Markers specific to each patient's disease were identified at the time of diagnosis on the biopsy of the primary tumor or bone marrow aspiration and an immunohistochemistry (IHC) was performed on the FFPE ITT for each patient to evidence his disease markers. PCR analyses on the FFPE tissue were also conducted when a specific gene rearrangement was available. MAIN RESULTS AND THE ROLE OF CHANCE: The mean age at diagnosis and ITT biopsy of the 28 boys was 7.5 years (age range: 19 months-16 years old). Examination of ITT of the 28 boys on H&E stained sections did not detect malignant cells. Using IHC, we found contamination by cancerous cells using markers specific to the patient's disease in 10 of 28 boys, with a higher rate in patients diagnosed with ALL (57%, n = 8/14) compared with lymphoma (14%, n = 2/14) (P-value < 0.05). PCR showed contamination in three of 15 patients who had specific rearrangements identified on their bone marrow at the time of diagnosis; one of these patients had negative results from the IHC. Compared to age-related reference values of the number of spermatogonia per ST (seminiferous tubule) (Spg/ST) throughout prepuberty of healthy patients from a simulated control cohort, mean spermatogonial numbers appeared to be decreased in all age groups (0-4 years: 1.49 ± 0.54, 4-7 years: 1.08 ± 0.43, 7-11 years: 1.56 ± 0.65, 11-14 years: 3.37, 14-16 years: 5.44 ± 3.14). However, using a cohort independent method based on the Z-score, a decrease in spermatogonia numbers was not confirmed. LIMITATIONS, REASONS FOR CAUTION: The results obtained from the biopsy fragments that were evaluated for contamination by cancer cells may not be representative of the entire cryostored ITT and tumor foci may still be present outside of the biopsy range. WIDER IMPLICATIONS OF THE FINDINGS: ITT from boys diagnosed with a hematological malignancy could bear the risk for cancer cell reseeding in case of autotransplantation of the tissue. Such a high level of cancer cell contamination opens the debate of harvesting the tissue after one or two rounds of chemotherapy. However, as the safety of germ cells can be compromised by gonadotoxic treatments, this strategy warrants for the development of adapted fertility restoration protocols. Finally, the impact of the hematological cancer on spermatogonia numbers should be further explored. STUDY FUNDING/COMPETING INTEREST(S): The project was funded by a grant from the FNRS-Télévie (grant n°. 7.4533.20) and Fondation Contre le Cancer/Foundation Against Cancer (2020-121) for the research project on fertility restoration with testicular tissue from hemato-oncological boys. The authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kourta D, Camboni A, Saussoy P, et al. Evaluating testicular tissue for future autotransplantation: focus on cancer cell contamination and presence of spermatogonia in tissue cryobanked for boys diagnosed with a hematological malignancy. Hum Reprod. 2024. PMID: 38227814. doi:10.1093/humrep/dead271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。